Merdad Parsey
Director · ArriVent BioPharma, Inc.
- 2024
- Jun 23, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Merdad Parsey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
- Johanna Mercier - $18.17M in GILD purchases and sales in the last 12 months
- HILLHOUSE INVESTMENT MANAGEMENT, LTD. - $12.98M in AVBP purchases and sales in the last 12 months
- Deborah H. Telman - $6.59M in GILD purchases and sales in the last 12 months
- Andrew D. Dickinson - $4.38M in GILD purchases and sales in the last 12 months
- Anthony Welters - $2.68M in GILD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Merdad Parsey?
Merdad Parsey is a corporate insider, tracked as Director of ArriVent BioPharma, Inc. (AVBP). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Merdad Parsey last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 6 filings going back to 2024.
Has Merdad Parsey been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($17.60M) across all tracked filings.
